Central and Peripheral Airway Sites of Nitric Oxide Gas Exchange in COPD

被引:22
|
作者
Gelb, Arthur F. [1 ,3 ]
Taylor, Colleen Flynn
Krishnan, Anita
Fraser, Christine
Shinar, Chris M. [4 ]
Schein, Mark J. [2 ]
Osann, Kathryn [5 ]
机构
[1] Lakewood Reg Med Ctr, Div Pulm, Dept Med, Lakewood, CA USA
[2] Lakewood Reg Med Ctr, Dept Radiol, Lakewood, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Orange Coast Mem Med Ctr, Dept Performance Improvement & Patient Safety, Fountain Valley, CA USA
[5] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA
关键词
OBSTRUCTIVE PULMONARY-DISEASE; EXHALED AIR; FLOW-RATE; ALVEOLAR; ASTHMA; EXACERBATIONS; INFLAMMATION; HEALTHY; SPUTUM; NO;
D O I
10.1378/chest.09-1522
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: This study investigated sites of nitric oxide (NO) gas exchange and response to inhaled corticosteroids (ICS) in patients with COPD and varying extents of emphysema. Methods: This was a prospective, randomized, single-blind, crossover study in treated, stable, ex-smoking patients with COPD who were ICS and leukotriene receptor antagonists naive. Lung function, high-resolution thin-section CT scan of the lung, and exhaled NO were measured at 50, 100, 150, and 200 mL/s. Airway NO was adjusted for NO axial backdiffusion. Results: In 39 (18 women), clinically stable ex-smokers with COPD aged 73 +/- 9 years (mean +/- SD) on salmeterol 50 mu g (S50) bid, after 180 mu g aerosolized albuterol, FEV1 (L) was 52% +/- 12% predicted and FEV1/FVC was 55% +/- 6%. Compared with 20 (12 men) age-matched controls, 39 patients with COPD had normal large airway NO flux and small airway/alveolar NO. Subsequently, 19 patients with COPD (Group A) were randomized and continued on S50, and 20 (Group B) were randomized to fluticasone propionate 250 mu g (F250)/S50 bid for 86 +/- 16 days. Group A (S50) patients were then switched to F250/S50, and 12 of 19 completed 77 +/- 15 days; there was significant (P < .001) reduction only in the exhaled fraction of NO (FENO) at 50 mL/s and large airway NO flux. In 20 patients with COPD initially randomized to F250/S50 (Group B), after 57 +/- 22 days of S50 in 16 of 20 patients there was a significant (P = .04) increase only in (FENO) at 50 mL/s and large airway NO flux, which was not reduced after 60 +/- 23 days of fluticasone propionate 100 mu g (F100)/S50(P = .07). There was no correlation between NO gas exchange and CT-scored emphysema. Conclusions: In COPD, there was; normal NO gas exchange in both large and small airways/alveoli and only large airway NO flux was suppressed with F250/S50 but not F100/S50, despite varying extents of emphysema. Peripheral NO must be corrected for axial NO backdiffusion to avoid spurious conclusions. CHEST 2010; 137(3):575-584
引用
收藏
页码:575 / 584
页数:10
相关论文
共 50 条
  • [41] Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD
    Bazeghi, Nassim
    Gerds, Thomas A.
    Budtz-Jorgensen, Esben
    Hove, Jens
    Vestbo, Jorgen
    RESPIRATORY MEDICINE, 2011, 105 (09) : 1338 - 1344
  • [42] Effects of Extra-Fine Inhaled and Oral Corticosteroids on Alveolar Nitric Oxide in COPD
    Short, Philip M.
    Williamson, Peter A.
    Lipworth, Brian J.
    LUNG, 2012, 190 (04) : 395 - 401
  • [43] Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD
    Liu, Xiaoqian
    Zhang, Hong
    Wang, Ying
    Lu, Yue
    Gao, Yanli
    Lu, Yong
    Zheng, Chunming
    Yin, Danfeng
    Wang, Shurui
    Huang, Kewu
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (02) : 121 - 127
  • [44] Nitric oxide in allergic airway inflammation
    Payne, Donald N. R.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 3 (02) : 133 - 137
  • [45] Exhaled nitric oxide correlated with induced sputum findings in COPD
    Silkoff, PE
    Martin, D
    Pak, J
    Westcott, JY
    Martin, RJ
    CHEST, 2001, 119 (04) : 1049 - 1055
  • [46] Measurement of nitric oxide and assessment of airway diseases in children: an update
    Pappalardo, Maria G.
    Parisi, Giuseppe F.
    Tardino, Lucia
    Savasta, Salvatore
    Brambilla, Ilaria
    Marseglia, Gian L.
    Licari, Amelia
    Leonardi, Salvatore
    MINERVA PEDIATRICA, 2019, 71 (06) : 524 - 532
  • [47] Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD
    Santus, Pierachille
    Radovanovic, Dejan
    Mascetti, Susanna
    Pauletti, Alessia
    Valenti, Vincenzo
    Mantero, Marco
    Papi, Alberto
    Contoli, Marco
    PHARMACOLOGICAL RESEARCH, 2018, 133 : 160 - 169
  • [48] Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma
    Walker, W. T.
    Liew, A.
    Harris, A.
    Cole, J.
    Lucas, J. S.
    RESPIRATORY MEDICINE, 2013, 107 (03) : 380 - 386
  • [49] Fractionated exhaled nitric oxide in COPD patients
    Schumann, Desiree
    Kostikas, Konstantinos
    Schilter, Daniel
    Louis, Renaud
    Grize, Leticia
    Tamm, Michael
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [50] Assessment of Small-Airways Disease Using Alveolar Nitric Oxide and Impulse Oscillometry in Asthma and COPD
    Williamson, Peter A.
    Clearie, Karine
    Menzies, Daniel
    Vaidyanathan, Sriram
    Lipworth, Brian J.
    LUNG, 2011, 189 (02) : 121 - 129